Synergia Medical is pioneering optoelectronics for neural stimulation therapies by developing an innovative, powerful and versatile neural stimulation technological platform.
By doing so, Synergia Medical will improve patients’ quality of life and pave the way to new personalized therapies.
Full range of applications
Synergia Medical’s technology could benefit numerous neurological diseases such as chronic pain, Parkinson’s disease, drug-resistant epilepsy, sleep apnoea and depression.
Synergia Medical’s current IP portfolio includes non-metallic encapsulation of neurostimulators, fast-charging wireless system, a custom optical lead, miniaturized photovoltaic cells and an enhanced electrode.
News and Events
SYNERGIA MEDICAL STRENGTHENS ITS MANAGEMENT TEAM WITH THE APPOINTMENT OF DAN SCHERRER AS COO
Synergia Medical announced the appointment of Dan Scherrer as Chief Operating Officer. Dan Scherrer brings over 20 years of experience manufacturing, supply chain, quality management and product development in the medical device field.
SYNERGIA MEDICAL RECOGNISED BY EIC ACCELERATOR FOR THE EXCELLENT POTENTIAL OF ITS EPILEPSY TREATMENT SOLUTION
Synergia Medical announced that it has been awarded a €2.5 million grant from the EIC Accelerator program with the potential for an equity investment from the EU in the future Series C fund raising of a further €7.5 million.
INS Barcelona 2022
The Synergia Medical team was delighted to display 4 scientific posters at INS Barcelona 2022.